Osaka, Japan

Naoki Nagahara

This inventor holds 18 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 5 EPO patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 1992-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Nagahara. Retrieved from https://idiyas.com/inventor/naoki-nagahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 77.8


 

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 331(Granted Patents)


Location History:

  • Sakai, JP (1992)
  • Amagasaki, JP (1996 - 2002)
  • Itami, JP (1998 - 2002)
  • Kawabe-gun, JP (2003)
  • Osaka, JP (2010 - 2015)

Company Filing History:


Years Active: 1992-2015

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: **Naoki Nagahara: Innovator in Pharmaceutical Sciences**

Introduction

Naoki Nagahara, based in Osaka, Japan, is a notable inventor with a remarkable portfolio of 18 patents. His work primarily focuses on the pharmaceutical industry, addressing the complexities of drug delivery and formulation processes. Nagahara's innovations have significant implications for the controlled release of active ingredients, improving therapeutic outcomes.

Latest Patents

Among his recent patents, one significant invention is the **Method for producing granules**. This method enhances the consistency of elution profiles for granules containing biologically active substances. By heating the granules to approximately 50°C or higher and maintaining this temperature for at least one minute, the method effectively reduces variations in the elution profile. Furthermore, it specifies optimal spray speeds and feeding weights for an efficient process using a centrifugal fluidized bed coating machine.

Another pivotal patent is the **Controlled release composition**, which presents a novel formulation that releases a proton pump inhibitor in a controlled manner. This composition is designed to release the active ingredient in multiple steps, utilizing different release-controlled parts to achieve varying rates. The strategic design ensures that the release of the active ingredient occurs sequentially, maximizing its therapeutic effectiveness.

Career Highlights

Naoki Nagahara’s career includes pivotal roles at prominent institutions such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His contributions at these organizations reflect a strong commitment to advancing pharmaceutical innovations and improving patient care through precise drug delivery systems.

Collaborations

During his career, Nagahara has collaborated with esteemed colleagues like Yohko Akiyama and Hiroto Bando. These partnerships have significantly enriched his research and contributed to the development of cutting-edge pharmaceutical technologies.

Conclusion

Naoki Nagahara stands out as a key figure in pharmaceutical innovation, with a strong focus on enhancing drug formulation and delivery systems. His extensive patent portfolio not only underscores his inventiveness but also highlights the practical applications of his work in improving patient outcomes. Through continuous collaboration and research, Nagahara remains dedicated to driving forward the field of pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…